France· FR:65074386
DANTRIUM INTRAVEINEUX, lyophilisat pour préparation injectable
A dantrolene product containing dantrolène sodique, registered in France by NORGINE (PAYS-BAS). The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Dantrolene is registered in 16 of 19 countries.
Countries holding a registration under ATC M03CA01 (dantrolene), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Dantrolene · ATC M03CA01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dantrolene costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $1.64 in United States to $5.92 in Finland — a ×3.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Dantrolene · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$5.92
- US United States$1.64 (acquisition cost)
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DANTROLÈNE SODIQUE
- Manufacturer
- NORGINE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- M03CA01
- ATC class
- Dantrolene
- Defined daily dose
- 0.1 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009554873191 flacon(s) en verre avec un dispositif de filtration à usage unique
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
93 interactions on record for dantrolene.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dantrolene · interactions on record
93 records
- 16 severe
- 60 moderate
- 17 info
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dantrolene in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAgilus 120mg powder for solution for injection vialsForum Health Products Ltd
- United StatesDantriumPar Health USA, LLC
- SwitzerlandAgilus 120 mg, Pulver zur Herstellung einer InjektionslösungNorgine AG
- IrelandAgilus 120 mg powder for solution for injectionNorgine B.V.
- CanadaDANTRIUM CAPSULESENDO OPERATIONS LTD.
- NetherlandsAgilus 120 mg poeder voor oplossing voor injectieNorgine B.V.
- FinlandAgilusNorgine B.V.
- CzechiaAGILUSNorgine B.V., Amsterdam
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Dantrium Iv
- Germany · Dantamacrin, Dantrolen I.V.
- United Kingdom (Northern Ireland) · Agilus, dantrium
- Ireland · Dantrium
- Iceland · Agilus
- Italy · Dantrium
- Liechtenstein · Agilus
- Netherlands · Dantrium
- Norway · Agilus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/13902c19-32ab-4cd6-a28f-54081db15012 GET /v1/drugs/13902c19-32ab-4cd6-a28f-54081db15012?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65074386",
"date_amm": "1984-07-17",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DANTROLÈNE SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "lyophilisat pour préparation injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about dantrolene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.